News
Central Nervous System Tumors: A Challenge for Navigators and Patients
Neoadjuvant Therapy in Melanoma Tied to High Pathological Response Rates
Depth of Response to TKIs, Immunotherapies Correlates to Longer PFS and OS
How Safe Is Resumption of Checkpoint Inhibitor Therapy After an Initial Event of Immune-Mediated Diarrhea and Colitis?
Location of Body Fat Linked to Advanced, Fatal Prostate Cancer
How to Treat Melanoma After Checkpoint Inhibitors Fail
Adjuvant Ipilimumab Determined to Increase Overall Survival in High-Risk Melanoma
Promising Early Results for Preoperative Atezolizumab in Resectable NSCLC
Ruxolitinib is Associated With Improved Renal Function in Patients With Primary Myelofibrosis
Few Oncologists Refer Patients to Weight Management Programs
Front-Line Resilience for Oncology Nurse Navigators
Transition Care Navigation Utilizing a Predictive Model (LACE+) to Impact Readmission Rates and Transfer of Care From Inpatient to Outpatient: A Programmatic Research Study
Responsive Engagement and Cessation in Cancer Health (REACCH): A Nurse Navigator-Led Comprehensive Tobacco Cessation Program at the University of Arizona Cancer Center
Implementation of a Standardized Navigation Barrier Assessment for Oncology Patients Based on a Person-Centered Framework
Feasibility of Medication Coordination With Lay Navigators in Outpatient Oncology Clinics
The Use of Technology in Multidisciplinary Communication to Improve Patient-Centered Care Coordination: A Systemic Review
Keynote Address: The Role of Navigation in a Changing Healthcare Environment
Navigating Lung Cancer: Screening, Treatment, and Post-Treatment Considerations
Navigating Gastrointestinal/Pancreatic Cancers: Screening, Treatment, and Post-Treatment Considerations
Featured
-
IV Line Flush Guidelines
Are there any published studies regarding the amount of saline used to flush a line before the next medication can be hung? -
ONA Nav Summit 2019
Coverage from this year’s ONA Navigation Summit. -
Patient, Nurse Safety in Lu-177 Administration
An overview of safe handling concerns regarding handling and administration of a recently approved receptor-binding radionuclide. -
Issues in Cancer Survivorship
This month’s featured section explores all aspects of the transition from patient to survivor. -
Let Us Answer Your Oncology Question
Our oncology professionals address your clinical questions.
Features
ASCO: Survival Up With Ribociclib in Advanced Breast Cancer
OS longer for premenopausal patients receiving ribociclib in addition to endocrine therapy.
Benefit Seen from Frontline Pembrolizumab Plus Axitinib in Patients With Intermediate- or Poor-Risk Advanced RCC
Efficacy benefits of pembrolizumab plus axitinib over sunitinib were also observed in patients with disease characterized by sarcomatoid features.
Advisor Forum
Effectiveness of Generic vs Brand Name Chemotherapy Drugs
Are generic chemotherapy drugs as effective as the brand name drug?
Frequency of Chemotherapy, Medication Desensitization
How often should a patient be desensitized to medications?
Popcorn Lung: A New Threat From e-Cigarettes
What is “popcorn lung” and what causes it?
Drug Lookup
Search our drug information database which contains an extensive list of drugs.
Powered By : 
Fact Sheets
Alcohol and Cancer Risk (Fact Sheet)
This fact sheet examines how alcohol consumption can affect cancer risk.
How to Prevent Skin Cancer (Fact Sheet)
Skin cancer is the most commonly diagnosed cancer in the US. Share this fact sheet with your patients to protect them.
Challenges Faced By Oncology Nurses
Digital Issue
Editorial Board
Eucharia Borden, MSW, LCSW, OSW-CAnn J. Brady, MSN, RN-BC, CHPN
Jiajoyce R. Conway, DNP, CRNP, AOCNP
Marianne Davies, DNP, ACNP, AOCNP
Frank dela Rama, RN, MS, AOCNS
Donald R. Fleming, MD
Leah A. Scaramuzzo, MSN, RN-BC, AOCN
Lisa A. Thompson, PharmD, BCOP
Rosemarie A. Tucci, RN, MSN, AOCN
Kara M.L. Yannotti, MMH, BSN, RN, CCRP
